China COVID-19 Vaccine on trial
China reached an important new level of vaccine development with the start of the phase three clinical trial of an inactivated vaccine against COVID-19. It is the first vaccine to reach a late-stage, mass scale human trial,
The Institute of Microbiology of the Chinese Academy of Sciences said in a statement that Chinese authorities approved the phase one trial of the nation’s first protein vaccine against COVID-19.
Comments
Post a Comment
Please share your thoughts with us!